Product Information
LANSOPRAZOLE DR 30 MG CAPSULE is a generic product labeled by Ascend Laboratories, LLC, priced at $0.1071 per EA under NDC 67877027590. Its NADAC has been published 338 times since Mar 4, 2020.
FDA first approved this application on Jan 18, 2019. Its Orange Book therapeutic-equivalence code is AB — FDA rates it therapeutically equivalent to (substitutable for) its reference product.
Strength
30 mg/1
Manufacturer
Ascend Laboratories, LLCNDC
67877027590
Classification
Generic
Dosage Form
CAPSULE, DELAYED RELEASE
Route
ORAL
Effective Date
8/19/2026
Active Ingredients
LANSOPRAZOLEApproval Type
Generic (ANDA)
FDA Application
ANDA207394FDA Approved
1/18/2019
TE Code
AB
On Market Since
1/20/2019
Pharmacological Classes
Price Statistics
The NADAC for LANSOPRAZOLE DR 30 MG CAPSULE has been published 338 times since Mar 4, 2020, and over the history we have for it it has declined 36.8%. The table below summarizes its recorded NADAC range and movement.
| Current price | $0.1071 per EA |
|---|---|
| All-time high | $0.1828 (Jul 15, 2020) |
| All-time low | $0.0754 (Nov 20, 2024) |
| 52-week high | $0.1089 |
| 52-week low | $0.1049 |
| Median price | $0.1126 |
| Average price | $0.1234 |
| Largest weekly change | -28.6% (Nov 20, 2024) |
| Weeks tracked | 338 |
| Tracking since | Mar 4, 2020 |
Generic Alternatives
The matcher finds 6 manufacturers offering a NADAC-published product with this drug's active ingredient and strength in a comparable dosage form (cheapest from each manufacturer, up to 10 shown below). None of the shown alternatives sit below the current price. These are candidates to verify clinically, not guaranteed substitutes — see our generic drug prices guide.
Related Drugs
Same classification
Frequently asked questions
What is the NADAC price of LANSOPRAZOLE DR 30 MG CAPSULE?
The current National Average Drug Acquisition Cost (NADAC) for LANSOPRAZOLE DR 30 MG CAPSULE, manufactured by Ascend Laboratories, LLC, is $0.1071 per EA (NDC 67877027590), effective Aug 19, 2026.
How has the price of LANSOPRAZOLE DR 30 MG CAPSULE changed over time?
Over the history we have for it, the NADAC for LANSOPRAZOLE DR 30 MG CAPSULE has declined 36.8%. It has been tracked across 338 weekly CMS publications since Mar 4, 2020.
What are the highest and lowest recorded NADAC prices for LANSOPRAZOLE DR 30 MG CAPSULE?
Since Mar 4, 2020, the NADAC for LANSOPRAZOLE DR 30 MG CAPSULE has ranged from a low of $0.0754 (Nov 20, 2024) to a high of $0.1828 (Jul 15, 2020), with a median of $0.1126 per EA.
Are there cheaper alternatives to LANSOPRAZOLE DR 30 MG CAPSULE?
6 manufacturers publish a NADAC-priced product with the same active ingredient and strength as LANSOPRAZOLE DR 30 MG CAPSULE in a comparable dosage form, but none are currently priced below it.
Who manufactures LANSOPRAZOLE DR 30 MG CAPSULE?
LANSOPRAZOLE DR 30 MG CAPSULE (NDC 67877027590) is labeled by Ascend Laboratories, LLC, and CMS classifies it as a generic product.